Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Covid-19

Study type

Observational

Funder types

Other

Identifiers

NCT04362345
7773 (Other Identifier)

Details and patient eligibility

About

The aim of the research is to improve patient management by rapidly identifying, based on the terrain and clinical and biological characteristics, those patients likely to present a severe form of ARDS at risk of leading to intensive care

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Major patient (≥18 years of age)
  • Admitted in March 2020 for confirmed Covid-19 lung disease (nasopharyngeal smear or sputum with SARS-CoV-2 positive PCR).

Exclusion criteria

  • Patient who has expressed opposition to participation in the study.
  • Mild forms of infection that do not require hospitalization,
  • Subject under safeguard of justice
  • Subject under guardianship or trusteeship

Trial contacts and locations

0

Loading...

Central trial contact

Saïd CHAYER, PhD, HDR; Yves HANSMANN, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems